Data / Drug companies / Vespyr Brands LLC
Vespyr Brands LLC: 12 products in the FDA NDC directory, labeler code 71179
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Vespyr Brands LLC (labeler code 71179) lists 12 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 12 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on February 1, 2026.
The request: Watch Vespyr Brands LLC (FDA labeler code 71179): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71179
- Products in commercial distribution
- 12
- Packages
- 26
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 12
- Flagged as original packager
- 6 of 6 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- April 21, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 6 | 50% |
| Generic drugs (ANDA) | 4 | 33.3% |
| Over the counter monograph drugs | 2 | 16.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 12 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Zinc gluconate | 3 | 14 |
| Guaifenesin | 1 | 123 |
| Zinc gluconate, sambucus nigra, glycyrrhiza glabra | 1 | 1 |
| Caffeine | 1 | 38 |
| Loratadine | 1 | 125 |
| Guaifenesin and dextromethorphan hbr | 1 | 26 |
| Naproxen sodium and pseudoephedrine hydrochloride | 1 | 3 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lozenge | 6 | 50% |
| Tablet, extended release | 3 | 25% |
| Tablet | 2 | 16.7% |
| Capsule | 1 | 8.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| CONTAC Allergy | 71179-010 | Tablet | Generic drugs (ANDA) | February 1, 2026 |
| Naproxen sodium and pseudoephedrine hydrochloride cold and sinus | 71179-816 | Tablet, extended release | Generic drugs (ANDA) | August 7, 2024 |
| Contac cold and flu | 71179-003 | Capsule | Over the counter monograph drugs | June 29, 2024 |
| Cold-EEZE Cold Remedy honey lemon | 71179-340 | Lozenge | Unapproved homeopathic products | April 19, 2024 |
| Vivarin | 71179-018 | Tablet | Over the counter monograph drugs | June 19, 2023 |
| Guaifenesin and Dextromethorphan HBr | 71179-011 | Tablet, extended release | Generic drugs (ANDA) | July 14, 2022 |
| Cold-EEZE Cold Remedy | 71179-342 | Lozenge | Unapproved homeopathic products | June 29, 2022 |
| Cold-EEZE Cold Remedy | 71179-324 | Lozenge | Unapproved homeopathic products | June 29, 2022 |
| Guaifenesin | 71179-002 | Tablet, extended release | Generic drugs (ANDA) | June 27, 2022 |
| Cold-EEZE Cold Remedy | 71179-320 | Lozenge | Unapproved homeopathic products | June 23, 2022 |
| Cold-EEZE Cold Remedy | 71179-323 | Lozenge | Unapproved homeopathic products | May 9, 2022 |
| Cold-EEZE Cold Remedy | 71179-343 | Lozenge | Unapproved homeopathic products | April 21, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.